Blueprint Medicines Operating Income 2014-2024 | BPMC

Blueprint Medicines operating income for the twelve months ending September 30, 2024 was $-0.276B, a 48.03% decline year-over-year.

  • Blueprint Medicines annual operating income for 2023 was $-0.486B, a 9.53% decline from 2022.
  • Blueprint Medicines annual operating income for 2022 was $-0.538B, a 16.27% decline from 2021.
  • Blueprint Medicines annual operating income for 2021 was $-0.642B, a 307.96% decline from 2020.

Blueprint Medicines Operating Income 2014-2024 | BPMC

  • Blueprint Medicines annual operating income for 2023 was $-0.486B, a 9.53% decline from 2022.
  • Blueprint Medicines annual operating income for 2022 was $-0.538B, a 16.27% decline from 2021.
  • Blueprint Medicines annual operating income for 2021 was $-0.642B, a 307.96% decline from 2020.